 |
 |
BrainStorm Aims to be the First Worldwide to Win FDA Approval to Conduct Trials for PD Using Adult Stem Cells (08/22/2007) Source URL : http://www.globes.co.il/serveen/globes/DocView.asp?did=1000246496&fid=1725 August 22, 2007 -- Biopharmaceutical company BrainStorm Cell Therapeutics Ltd. has arranged a first meeting with the US Food and Drug Administration (FDA) to coordinate clinical trials for its flagship product for the treatment of Parkinson's disease. The company said it aims to be the first worldwide to win approval to conduct trials using adult stem cells taken from patients. BrainStorm has hired Dr. Andra E. Miller, director of cell and gene therapies of the Biologics Consulting Group, Inc. as consultant to handle the company's negotiations with the FDA. BrainStorm president Chaim Lebovits said, "BrainStorm's preclinical research related to Parkinson's disease has reached the stage where we are ready to approach the FDA about initiating clinical Phase I trials." Rayilyn Brown Board Member AZNPF Arizona Chapter National Parkinson's Foundation [log in to unmask] ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn